Manulife (Manufacturers Life Insurance)
CUE icon

Manulife (Manufacturers Life Insurance)’s Cue Biopharma CUE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-474
Closed -$69.4K – 3042
2022
Q1 		$69.4K Sell
474
-98
-17% -$20.8K ﹤0.01% 3014
2021
Q4 		$194 Sell
572
-16
-3% -$6.19K ﹤0.01% 2905
2021
Q3 		$257K Sell
588
-34
-5% -$11.9K ﹤0.01% 2795
2021
Q2 		$217K Sell
622
-16
-3% -$6.2K ﹤0.01% 3052
2021
Q1 		$233K Sell
638
-2
-0.3% -$823 ﹤0.01% 2787
2020
Q4 		$240K Buy
640
+86
+16% +$34.4K ﹤0.01% 2660
2020
Q3 		$250K Hold
554
– – ﹤0.01% 2420
2020
Q2 		$388K Buy
554
+105
+23% +$76.1K ﹤0.01% 2089
2020
Q1 		$191K Sell
449
-1
-0.2% -$485 ﹤0.01% 2340
2019
Q4 		$214K Sell
450
-35
-7% -$11K ﹤0.01% 2550
2019
Q3 		$129K Buy
485
+42
+9% +$10.1K ﹤0.01% 2760
2019
Q2 		$119K Buy
+443
New +$110K ﹤0.01% 2854
2018
Q3 		– Sell
-505
Closed -$179K – 3109
2018
Q2 		$179K Buy
505
+249
+97% +$99K ﹤0.01% 3207
2018
Q1 		$107K Buy
+256
New +$117K ﹤0.01% 3380

Other funds holding CUE

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CUE Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Cue Biopharma (CUE) in Q2 2022, closing a stake of 474 shares — an estimated $69.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CUE in Q1 2018 and held it in 14 quarters. The position peaked at $388K in Q2 2020. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Cue Biopharma position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 474 Cue Biopharma shares in Q2 2022, an estimated $69.4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Cue Biopharma in Q1 2018 and held it in 14 quarters.
  • Manulife (Manufacturers Life Insurance)'s Cue Biopharma position peaked at $388K in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.